Please login first
Events About
Contact
My Submissions
The 3rd International Electronic Conference on Biomolecules

The 3rd International Electronic Conference on Biomolecules

The 3rd International Electronic Conference on Biomolecules

Part of the International Electronic Conference on Biomolecules series
23–25 Apr 2024
Event's Timezone: Central European Time
Biomolecular Structures and Functions, Molecular Mechanisms, Biomolecular Interactions and Networks, Biomaterials, Biocatalysis and Enzyme Engineering, bioinformatics and computational biology
Calendar
Bookmark
Bookmark event Remove event from bookmarks
Add this event to bookmarks
Contact Us Become a Sponsor

The IECBM 2024 is closed! Thanks for your participation!

Welcome to submit your paper to the conference's special issue of Biomolecules with 20% discount!
Deadline: 31 July 2024.

Submit your proceeding paper (4-8 pages) to Biology and Life Sciences Forum for free!
Deadline: 10 June 2024.

Welcome from the Chair

Dear Colleagues,

It is with great enthusiasm that we announce the 3rd International Electronic Conference on Biomolecules (IECBM2024). The conference is organized by the MDPI open-access journal Biomolecules (ISSN: 2218-273X, Impact Factor 5.5), and will be held online from 23 to 25 April 2024.

This conference will provide leading scientists working in the field with an online platform on which to share their latest research and engage in exciting discussions. The main topics and sessions of the conference are:

Biomolecular Structures and Functions;
Molecular Mechanisms in Cellular Processes;
Biomolecular Interactions and Networks;
Biomaterials Design and Characterization;
Biocatalysis and Enzyme Engineering;
Bioinformatics and Computational Biology.

This is an excellent opportunity for biomolecular researchers and scientists to interact with each other, communicate with their colleagues, learn from each other, share ideas and results, help solve problems, and suggest alternative options for a better future. As well as the energetic and dynamic nature of the virtual international conference, another advantage is that you do not need to travel anywhere to attend the conference. You can take advantage of the above opportunities from wherever you live.

Under the virtual conference settings, there are additional advantages: (1) engagement tools that keep energy levels high, (2) participants are given a voice, (3) far stronger attention is received while one is talking, (4) Q&A through “Chat” is also possible if you do not wish to raise your question verbally, (5) polls, (6) feedback through Chat, (7) use of symbols under “Reactions” function to show your voice, appreciation, or a request, (8) greater reach with remote audiences, and (9) the ability to deliver live and pre-recorded presentations simultaneously.
All accepted abstracts will be available online in Open Access form on Sciforum.net during and after the conference.

Kind regards,
Prof. Dr. Vladimir N. Uversky, PhD, DSc, FRSB, FRSC
Department of Molecular Medicine, University of South Florida, USA

Follow the conference organizer on Social Media

Event Chair

Prof. Dr. Vladimir N. Uversky

Department of Molecular Medicine, University of South Florida, USA

Introduction
Bio
Vladimir Uversky is Professor at the College of Molecular Medicine, University of South Florida. He is a biophysicist and obtained his PhD and Doctor of Science (DSc) in Physics and Mathematics at the Moscow Institute of Physics and Technology (1991) and at the Institute Experimental and Theoretical Biophysics, Russian Academy of Sciences (1998), respectively. He spent his early career investigating protein folding at the Institute of Protein Research and the Institute for Biological Instrumentation (Russia). In 1998, he moved to the University of California Santa Cruz to work on protein folding, misfolding, and protein intrinsic disorder. In 2004, he joined the Indiana School of Medicine and, in 2010, the University of South Florida, where he has since been continuing his studies on protein folding, misfolding, and intrinsically disordered proteins. Prof. Vladimir Uversky has authored over 980 scientific publications, edited numerous books, and is also serves as the editor of several scientific journals. He was included in Thomson Reuters list of Highly Cited Researchers in 2014-2020.

Session Chairs

Prof. Dr. Jürg Bähler

Department of Genetics, Evolution & Environment and Institute of Healthy Ageing, University College London, UK

Prof. Dr. Piero Crespo

CSIC Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Spain

Dr. Martin Muschol

Department of Physics, University of South Florida, USA

Dr. Tzanko I. Doukov

Macromolecular Crystallographic Group, Stanford Synchrotron Radiation Lightsource, National Accelerator Laboratory, Stanford University, Stanford, USA

Dr. Thomas R. Caulfield

Department of Neuroscience, Department of Cancer Biology, Department of Computational Biology, Department of Neurosurgery, Department of Clinical Genomics, Department of Biochemistry & Molecular Biology , Mayo Clinic, USA

Dr. Luigi Vitagliano

Institute of Biostructures and Bioimaging, CNR, Italy

Prof. Dr. María S. García Gutiérrez

Instituto de Neurociencias, Miguel Hernández University, Spain

Event Committee Members

Dr. Gal Bitan

David Geffen School of Medicine at UCLA, USA

Introduction
Bio
Gal Bitan got his PhD in organic chemistry from the Hebrew University of Jerusalem, Israel. During his postdoc at Brigham and Women's Hospital/Harvard Medical School, Boston, MA, Dr. Bitan worked on pathologic self-assembly of amyloid ß-protein (Aß) and made fundamental contributions to the study of early events in the pathologic cascades that cause Alzheimer's disease, including the discovery of one of the earliest oligomers in the assembly cascade, the paranucleus. In 2004, Dr. Bitan joined UCLA where he is currently a Professor of Neurology. His research program combines basic and translational research focused on neurodegenerative proteinopathies, including Alzheimer's disease, other tauopathies, Parkinson's disease, and atypical parkinsonian disorders.

Prof. Dr. Philip E. Bourne

Data Science Institute, University of Virginia, USA

Introduction
Bio
Philip E. Bourne, PhD, FACMI is the Stephenson Chair and Dean of the School of Data Science and a Professor in the Department of Biomedical Engineering at the University of Virginia. His current research focuses on systems pharmacology (notably neglected tropical diseases and protein kinase targets), structural bioinformatics, scholarly communication, professional development and the development and application of data science methods.

Dr. Maliha Zahid

Department of Cardiovascular Diseases, Mayo Clinic, USA

Introduction
Bio
Dr. Zahid is a clinician scientist/cardiologist at Mayo Clinic, Rochester, MN. Her area of expertise is cell penetrating peptide and her work revolves around tissue-specific cell penetrating peptides, cardiac- and lung-targeting families that she is developing as imaging agents and novel vectors for cell-specific delivery.
Research Keywords
cardiac-targeting peptide; protein transduction domains; cilia biology; ciliogenesis; genetics; congenital heart disease; lung targeting peptides; cell penetrating peptides

Prof. Dr. George Kokotos

Department of Chemistry, National and Kapodistrian University of Athens, Greece

Prof. Dr. Corrado Angelini

Department of Neurosciences, University of Padova, Italy

Prof. Dr. María S. García Gutiérrez

Instituto de Neurociencias, Miguel Hernández University, Spain

Introduction
Bio
María S. García Gutiérrez is Associate Professor of Pharmacology in the Department of Pharmacology at the Miguel Hernández University (UMH) and researcher at the Institute of Neurosciences, a joint center of the Spanish National Research Council (CSIC) and UMH. She specialized in translational research in neuropsychiatry and addictions, using animal models and processing samples from patients with these pathologies, with the aim of determining the mechanisms underlying them, identifying new targets and treatments, and possible biomarkers for prevention, diagnosis and prognosis. All the results of her research have been published in internationally prestigious peer-reviewed indexed journals (66 publications, first decile or quartile of their category). She has an H-index of 29 (Scopus).

Dr. Ping K. Yip

Blizard Institute, Queen Mary University of London, UK

Introduction
Bio
Dr Ping Yip is a Non-Clinical Senior Lecturer in Neuroscience at Queen Mary University of London. He completed his PhD on epilepsy under the supervision of Prof. Brian Meldrum and Dr Marcus Rattray at the Institute of Psychiatry which is now a school of King's College London. He spent much of his post-doctoral time at King's College London working under Prof. Stephen McMahon before he went to work with Prof. Adina Michael-Titus and Prof. John Priestley at Queen Mary University of London. His research focuses on neuroregeneration, neuroplasticity, neuroprotection, and neurodegeneration in several models of spinal cord and peripheral nerve injury in rats and mice. However, he has recently become interested in injury to the brain, in particular newborns with brain injury (Prof. Divyen Shah), adults with traumatic brain injury (Prof. Chris Uff), and motor neurone disease (Prof. Andrea Malaspina). The aim is to detect and understand brain injury from brain tissues and/or biofluids.
Research Keywords
spinal cord injury; traumatic brain injury; hypoxic-ischemic encephalopathy; peripheral nerve injury; amyotrophic lateral sclerosis; neuroinflammation; neuroregeneration; neuroplasticity; neuroprotection; biomarkers; omega-3 fatty acids; microRNA

Dr. Luciana Bordin

Department of Women's and Children's Health—SDB, University of Padova, Italy

Introduction
Research Keywords
protein purification; protein tyr-phosphorylation and dephosphorylation; inflammatory and metabolic dìseases; oxidative stress; eryptosis

Dr. Valentyn Oksenych

Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Norway

Introduction
Research Keywords
DNA repair; DNA damage response; genetics; primary immunodeficiency; B lymphocyte development; mouse models

Dr. Marek Schwendt

Psychology Department, University of Florida, USA

Introduction
Research Keywords
drug addiction; neuro-psychopharmacology; animal model; molecular mechanism

Dr. Xuexian Yang

Department of Molecular Genetics and Microbiology, School of Medicine, University of New Mexico, USA

Introduction
Research Keywords
cytokine signaling; unfolded protein response; transcriptional control; T helper cell; immunity and inflammation

Dr. William Cho

Department of Clinical Oncology, Queen Elizabeth Hospital, China

Introduction
Research Keywords
cancer biomarker; evidence-based medicine; extracellular vesicles; genomics; microRNA; molecular diagnostics; non-coding RNAs; nasopharyngeal carcinoma; next-generation sequencing; non-small cell lung cancer; proteomics; drug repurposing and bioinformatic

Prof. Dr. Chryssostomos Chatgilialoglu

Institute for Organic Synthesis and Photoreactivity (ISOF), National Research Council (CNR), Italy,
Center for Advanced Technology, Adam Mickiewicz University, Uniwersytetu Poznanskiego, Poland

Introduction
Research Keywords
free radical chemistry; biomimetic chemistry; organic synthesis; reaction mechanism; analytical protocols for biomarkers of radical stress; oxidative DNA damage; lipid modification; fatty acid-based lipidomics

Dr. Vadim Sumbayev

Medway School of Pharmacy, Universities of Kent and Greenwich, UK

Introduction
Research Keywords
biochemistry of immune responses; anti-tumour immunity; immunotherapy of cancer; cell stress and hypoxic signalling

Dr. Angelika Chroni

Institute of Biosciences and Applications, National Center for Scientific Research "Demokritos", Greece

Introduction
Bio
Dr. Angeliki Chroni, Research Director, heads the Lipoprotein group of the Institute of Biosciences and Applications of the NCSR “Demokritos” in Athens, Greece, since 2005. She holds a BSc in Chemistry (University of Athens, Greece, 1994) and a PhD in Biochemistry (University of Athens, Greece, 2000). Dr. Chroni worked as a post-doctoral fellow (2000-2005) at Boston University School of Medicine, USA. Dr. Chroni has been working for 20 years on understanding the structure-function relationship of apoA-I as well as of apoE, with emphasis on the elucidation of the perturbations in the functional properties of these apolipoproteins that result to human diseases. Recent activities include a) the elucidation of structural and functional defects as the underlying mechanism of the association of natural point mutations in apoA-I with alterations in HDL-cholesterol levels and cardiovascular risk, b) elucidation of the role of natural occurring apolipoprotein E4 variants and lipid homeostasis in Alzheimer’s disease pathogenetic processes, c) correction of structure of apoA-I and apoE variants displaying folding defects using libraries of small molecules and assays in a microplate set-up and d) the detailed characterization of changes in human HDL composition and functions in various pathogenic conditions in order to identify new biomarkers for cardiovascular risk and diagnosis, prognosis and therapy monitoring of disease.
Research Keywords
apolipoprotein structure and function; apolipoprotein A-I; apolipoprotein E; cholesterol; lipoprotein metabolism; dyslipidemia; atherosclerosis; Alzheimer's disease; inflammation

Dr. Tracey Martin

School of Medicine, Cardiff University, UK

Introduction
Bio
After a PhD in Molecular Biology at Cardiff University, Dr Martin began a Post-doctoral career at the then University of Wales College of Medicine (now Cardiff University), investigating the role of Hepatocyte Growth Factor (HGF) on endothelia. This led to the opportunity to examine HGF and its antagonist NK4 in cancer. She has since been involved in researching the role of Tight Junctions in cancer (during metastasis) and in endothelia (during angiogenesis). Her research interests include investigating how Tight Junctions can be modulated to control cancer cell dissociation and invasion, together with a continued interest in angiogenic factors and their role in metastasis. She is has a special interest in the mechanisms whereby HGF can control tight junction assembly and function in both cancer and endothelia. Her work has also involved the examination of HGF and how this cytokine influences stem cells markers in prostate cancer. Other research interests include the interaction of cancer cells in cell-adhesion and cell-signalling and in how the cell adhesion molecule VE-cadherin is involved in angiogenesis. Dr Martin is currently Senior Lecturer in Cell and Tumour Biology at the Cardiff University School of Medicine and is also the Director of Postgraduate Research.
Research Keywords
cancer metastasis; tight junctions; cell adhesion; molecular targets; blood–brain barrier; angiogenesis; endothelial cells; breast cancer

Prof. Dr. Andrey P. Anisimov

Laboratory for Plague Microbiology, Especially Dangerous Infections Department, State Research Center for Applied Microbiology and Biotechnology, Russia

Introduction
Bio
Deputy Director for Science of the State Research Center for Applied Microbiology and Biotechnology, Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Obolensk, Russia). He is a specialist in especially dangerous bacterial infections and obtained his PhD in Microbiology at the State Research Center for Applied Microbiology and Biotechnology. He obtained his Doctor of Science (DSc) in Microbiology at the Russian Research Anti-Plague Institute “Microbe” (Saratov, Russia). Dr. Anisimov made fundamental contributions to the study of bacterial pathogenesis and microevolution on the model of Yersinia pestis infection in order to improve means and methods of laboratory diagnosis, vaccine prophylaxis and treatment of plague.
Research Keywords
molecular bacteriology; infectious diseases; molecular biology of host-vector-pathogen interactions; microbial pathogenesis; virulence factors; vaccinology; biotechnology

Prof. Dr. Undurti N. Das

UND Life Sciences, USA,
Department of Medicine, Omega Hospitals, India,
Department of Biotechnology, Indian Institute of Technology, India

Introduction
Research Keywords
bioactive lipids; essential fatty acids; polyunsaturated fatty acids; prostaglandins; lipoxins; resolvins; protectins and maresins; reactive oxygen species; lipid peroxidation; cancer; rheumatology; inflammation; immune response; immune checkpoint inhibit

Prof. Dr. Haiteng Deng

School of Life Sciences, Tsinghua University, China

Introduction
Bio
Haiteng Deng is a professor at School of Life Sciences at Tsinghua University in Beijing. He is the director of the MOE Key Laboratory of Bioinformatics and the director of the Proteomics Center at Tsinghua University. He got his Ph.D. at Pennsylvania State University, and did his postdoctoral studies at University of Alberta and the Oak Ridge National Laboratory. He was a faculty member at Albert Einstein College of Medicine, University of Nebraska, and Rockefeller University. His research interests focus on (1) development and applications of proteomics, metabolomics, and chemical biology techniques; (2) understanding of the function and mechanism of redox biology in aging and neurodegeneration disease, and (3) development of novel therapeutic interventions and diagnostic biomarkers for aging associated diseases. Over the last five years, he has published 135 papers in peer reviewed journals.

Dr. Travis Beddoe

Centre for Livestock Interactions with Pathogens (CLiP), Department of Animal, Plant and Soil Sciences, AgriBio, Centre for AgriBiosciences, 5 Ring Road, La Trobe University, Australia

Introduction
Research Keywords
glycobiology; protein structure; protein-glycan and protein-protein interactions; host-pathogen interactions; recombinant protein expression

Dr. Frederick H. Silver

Department of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers, the State University of New Jersey, USA

Introduction
Research Keywords
collagen self-assembly; collagen structure and properties; extracellular matrix, tissue biomechanics; mechanotransduction; non-invasive characterization of tissues; wound healing

Dr. Guang Yu Deng

School of Materials & Engineering, University of Shanghai for Science and Technology, China

Introduction
Bio
Dr. Deng-Guang Yu received his B.S. degree from Beijing University of Chemical Technology, China, in 1991. After ten years working in a state-owned company, he went to Huazhong University of Science and Technology to get his PhD degree in 2007, Wuhan, China. He is presently a full professor in School of Materials and Chemistry in University of Shanghai for Science and Technology. His research mainly focus on drug delivery, nanomaterials and electrohydrodynamic atomization techniques, such as electrospinning, electrospraying and 3D printing.
Research Keywords
biomolecules; electrospinning; electrospraying; biomaterials; drug delivery

Program Overview

To view this content, you need to be logged in to Sciforum platform and registered to this specific event.

IECBM 2024 Program (DAY1)

IECBM 2024
Session 1. Biomolecular Structures and Functions
Session 3. Biomolecular Interactions and Networks

Date: 23rd April 2024 (Tuesday)
Time: 9:00 (CEST, Basel) | 03:00 (EDT, New York) | 15:00 (CST Asia, Beijing)

Time in CEST Speaker Title
09:00-09:10 Dr. Luigi Vitagliano
Prof. Dr. María S. García Gutiérrez
Session Chairs of S1
 Welcome from the session chair
09:10-09:30 Prof. Dr. Salvador Ventura
Keynote Speaker

A Structure-Based Approach to Tackle Protein Aggregation in Parkinson's Disease
09:30-09:50 Dr. Ping K. Yip
Keynote Speaker		 Using living patients’ brain tissue to study severe traumatic brain injury
09:50-10:05 Daniela Valeria Miniero
Selected Speaker		 The role of the charged residues in the C-gate of the yeast mitochondrial NAD+ transporter Ndt1p
10:05-10:20 Dr. Androulla Miliotou
Selected Speaker		 Genetic Insights into E-Cadherin Modulation: Exploring the Benefits of Synthetic Acetyl Hexapeptide-1 in Wound Healing and Anti-Aging for Dermo-cosmetics
10:20-10:35 Franklin Chamorro
Selected Speaker		 Maximizing Bioactive Compound Extraction: How do Factors Influence the Performance of the Microwave-Assisted Technique?
10:35-10:40 Prof. Dr. Piero Crespo
Session Chair of S3		 Welcome from the session chair
10:40-11:00 Dr. Xuexian Yang
Keynote Speaker		 The Extracellular Signal-Mediated Activation of IRE1 Promotes TH17 Responses
11:00-11:20 Prof. Dr. Fadi Bou-Abdallah
Keynote Speaker		 Human heteropolymer ferritin derived from a novel plasmid design: subunit composition, thermostability and physiological significance
11:20-11:35 Max Myakishev-Rempel
Selected Speaker		 Molecular structure considerations for the possibility of sequence-dependent DNA resonances
IECBM 2024
Session 4. Biomaterials Design and Characterization

Date: 23rd April 2024 (Tuesday)
Time: 15:00 (CEST, Basel) | 09:00 (EDT, New York) | 21:00 (CST Asia, Beijing)

Time in CEST Speaker Title
15:00-15:10
Dr. Martin Muschol
Session Chair		 Welcome from the session chair
15:10-15:40 Self-assembly of Macroscopic Biomaterials from Individual Amyloid Fibrils
15:40-16:10 Prof. Dr. Zhanhui Wang
Keynote Speaker		 Production and In Vitro Affinity Maturation of Broad-Specific Quinolones Nanobody
16:10-16:40 Prof. Dr. Anna Mitraki
Keynote Speaker		 Self-assembling protein and peptide folds as scaffolds for biomaterials design
16:40-17:00 Dr. Joel Giron Hernandez
Invited Speaker
 From cocoa waste to sustainable bioink: valorising pectin for circular economy-driven tissue engineering
17:00-17:20 Dr. Marcin Wekwejt
Selected Speaker		 p(HEMA)-enhanced magnesium phosphate cement: pioneering advances in dual-setting bone cements
17:20-17:40 Priyanka Meena
Selected Speaker		 Development of pH‑sensitive xanthan gum‑based hydrogel as a vehicle for delivering a hydrophobic drug
17:40-18:00 Raphael Oladokun
Selected Speaker
 COMSOL multiphysics computational studies of dielectrophoresis-based characterization and separation of tenogenically differentiating mesenchymal stem cells

IECBM 2024 Program (DAY2)

IECBM 2024
Session 2. Molecular Mechanisms in Cellular Processes

Date: 24th April 2024 (Wednesday)
Time: 10:00 (CEST, Basel) | 04:00 (EDT, New York) | 16:00 (CST Asia, Beijing)

Time in CEST Speaker Title
10:00-10:10

Prof. Dr. Jürg Bähler
Session Chair

 Welcome from the session chair
10:10-10:30 Functional characterization of a long non-coding RNA that affects cellular ageing
10:30-10:50 Prof. Dr. Anna Rita Franco Migliaccio
Keynote Speaker		 A drugable interaction between malignant megakaryocytes and neutrophils driven by the CXCL8/P-selectin axes as a driver for myelofibrosis
10:50-11:10

Prof. Vincenzo Brancaleone
Keynote Speaker

 Novel molecular mechanisms regulating the interplay between NO and H2S in hyperglycemia
11:10-11:30 Dr. Vadim Sumbayev
Keynote Speaker		 Tim-3-galecting-9 pathway as a crucial component of cancer immune evasion biochemical machinery and immune surveillance
11:30-11:50 Dr. Laurent Soulere
Keynote Speaker		 Inhibition of FtsZ with synthetic 2,6-difluorobenzamide derivatives: A comprehensive study
11:50-12:10 Dr. Irina Nesmelova
Keynote Speaker		 Effect of chemokine heterodimerization on CXCL12-mediated cell response.
12:10-12:25 Yannan Yu
Selected Speaker		 Exploring the Role of N-WASP in Breast Cancer Metastasis Through Mass Spectrometry and Potential Signalling Pathway Analysis
IECBM 2024
Session 6. Bioinformatics and Computational Biology

Date: 24th April 2024 (Wednesday)
Time: 15:00 (CEST, Basel) | 09:00 (EDT, New York) | 21:00 (CST Asia, Beijing)

Time in CEST Speaker Title
15:00-15:10 Dr. Thomas R. Caulfield
Session Chair
 Welcome from the session chair
15:10-15:40 Prof. Dr. Umesh Desai
Keynote Speaker
 Combinatorial Virtual Library Screening Algorithm in Discovering Highly Selective Glycosaminoglycan Sequences
15:40-16:10 Prof. Dr. Mire Zloh
Keynote Speaker		 Putative Epigenetic Targets of Cannabis Sativa for the Treatment of Multiple Sclerosis: A Network Pharmacology and Molecular Docking Approaches
16:10-16:40 Prof. Dr. Sanjoy Bhattacharya
Keynote Speaker		 Comparable Omics, the need for standardization, concepts of normalization and normativity
16:40-16:55 Wei Yao
Selected Speaker		 The Application of Machine Learning in CYP450s Specificity Prediction

IECBM 2024 Program (DAY3)

IECBM 2024
Poster Session

Date: 25th April 2024 (Thursday)
Time: 09:00-10:30 (CEST, Basel) | 03:00-04:30 (EDT, New York) | 15:00-16:30 (CST Asia, Beijing)
The poster list is available here!

IECBM 2024
Session 5. Biocatalysis and Enzyme Engineering

Date: 25th April 2024 (Thursday)
Time: 16:00 (CEST, Basel)| 10:00 (EDT, New York) | 22:00 (CST Asia, Beijing)

Time in CEST Speaker Title
16:00-16:10 Dr. Tzanko I. Doukov
Session Chair		 Welcome from the session chair
16:10-16:40 Prof. Dr. Tae Seok Moon
Keynote Speaker		 Systems and synthetic biology: constructing smart and programmable microbes to address global problems
16:40-17:10 Dr. Frederick H. Silver
Keynote Speaker
Use of Vibrational OCT to Study Skin Cancers
17:10-17:40 Dr. Benoit Coulombe
Keynote Speaker		 The PAQosome, a unique HSP90 co-chaperone for protein complex assembly and maturation; implication in disease
17:40-18:00 SHAKEEL ANSARI
Selected Speaker		 The stabilization and utility of β galactosidase immobilized on thiolated silica nanoparticles
18:00-18:15 Sumit Kumar
Selected Speaker		 Repurposing halophilic α-amylase for future biotechnological applications

Live Session Recordings

To view this content, you need to be logged in to Sciforum platform and registered to this specific event.

Abstract Book

The online version of the IECBM 2024 abstract book including program, all abstracts, and the complete poster list is available to browse and download!
Book of Abstracts

Keynote Speakers

Prof. Dr. Jürg Bähler

Department of Genetics, Evolution & Environment and Institute of Healthy Ageing, University College London, UK

Introduction
Research Keywords
gene regulation; genomics; transcriptomics; non-coding RNAs; genome function and evolution; fission yeast; cellular quiescence and ageing

Dr. Frederick H. Silver

Department of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers, the State University of New Jersey, USA

Introduction
Research Keywords
collagen self-assembly; collagen structure and properties; extracellular matrix, tissue biomechanics; mechanotransduction; non-invasive characterization of tissues; wound healing

Prof. Dr. Salvador Ventura

Institute of Biotechnology and Biomedicine, Autonomous University of Barcelona, Spain,
Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Spain

Introduction
Research Keywords
protein folding; protein aggregation; protein design; high-throughput screening; bioinformatics; amyloids; Parkinson; nanomaterials; phase separation; prions; drug discovery

Prof. Dr. Anna Rita Franco Migliaccio

Unit of Microscopic and Ultrastructural Anatomy, University Campus Bio-Medico, Italy,
Altius Institute for Biomedical Sciences, USA

Introduction
Research Keywords
hematopoietic stem cells; erythropoiesis; thrombopoiesis; cell therapy; hemoglobinopathies; myeloproliferative disorders

Prof. Dr. Zhanhui Wang

National Key Laboratory of Veterinary Public Health and Safety, Beijing Key Laboratory of Detection Technology for Animal-Derived Food, College of Veterinary Medicine, China Agricultural University, China

Introduction
Research Keywords
hapten design for chemical compound in food; production of recognition materials; immunoassay for food safety; food science and quality; antibiotic resistance; environmental drugs and toxins; veterinary medicine; zoonosis

Prof. Dr. Umesh Desai

Department of Medicinal Chemistry, Virginia Commonwealth University, USA,
Drug Discovery and Development, Institute for Structural Biology, Virginia Commonwealth University, USA

Introduction
Research Keywords
drug discovery; chemical biology; biological macromolecules; glycosaminoglycans; coagulation factors; cancer; viral infection; bio-mimetic design; enzyme mechanisms; computational biology; high throughput screening

Dr. Benoit Coulombe

Translational Proteomics Research Unit, IRCM, Canada,
Department of Biochemistry and Molecular Medicine, University of Montreal, Canada

Introduction
Research Keywords
Interests: single-cell proteomics; protein-protein interactions; protein complex assembly; PAQosome cochaperone; RNA polymerase; neurodegenerative disorders; zoonotic respiratory viruses; antivirals.

Dr. Marc Maresca

CNRS, Aix-Marseille University, Centrale Marseille, iSm2, Marseille, France

Introduction
Research Keywords
mycotoxins; fungal metabolites; antimicrobial; anticancer; antinflammatory; antioxidant

Dr. Ping K. Yip

Blizard Institute, Queen Mary University of London, UK

Introduction
Research Keywords
spinal cord injury; traumatic brain injury; hypoxic-ischemic encephalopathy; peripheral nerve injury; amyotrophic lateral sclerosis; neuroinflammation; neuroregeneration; neuroplasticity; neuroprotection; biomarkers; omega-3 fatty acids; microRNA

Dr. Xuexian Yang

Department of Molecular Genetics and Microbiology, School of Medicine, University of New Mexico, USA

Introduction
Research Keywords
cytokine signaling; unfolded protein response; transcriptional control; T helper cell; immunity and inflammation

Professor Vincenzo Brancaleone

Department of Science, University of Basilicata, Italy

Introduction
Research Keywords
endothelial and vascular dysfunction; resolution of inflammation; gender pharmacology

Prof. Dr. Mire Zloh

UCL School of Pharmacy, UK

Introduction
Research Keywords
computer-aided molecular design; molecular dynamics; docking; in silico screening; structural chemistry; NMR spectroscopy; antimicrobial resistance; multidrug resistance; efflux pump inhibition; antimicrobial peptides; dendrimer design

Prof. Dr. Tae Seok Moon

Department of Energy, Environmental and Chemical Engineering, Washington University in St. Louis, USA

Introduction
Research Keywords
biocontainment; probiotic; dynamic metabolic control; gene regulation; evolution; RNA regulators; biosensors; genetic circuits

Dr. Vadim Sumbayev

Medway School of Pharmacy, Universities of Kent and Greenwich, UK

Introduction
Research Keywords
biochemistry of immune responses; anti-tumour immunity; immunotherapy of cancer; cell stress and hypoxic signalling

Prof. Dr. Sanjoy Bhattacharya

Bascom Palmer Eye Institute, Miami, USA

Introduction
Research Keywords
proteomics; lipidomics; metabolomics; machine-learning; big data analytics; glaucoma; diabetic peripheral neuropathy; Alzheimer's disease; axon regeneration; growth cone

Prof. Dr. Fadi Bou-Abdallah

Department of Chemistry, State University of New York, USA

Introduction
Research Keywords
protein biochemistry; protein biophysics; protein thermodynamics; iron metabolism; protein structure-function relationship; protein-ligand binding; isothermal titration calorimetry; differential scanning calorimetry; kinetics

Dr. Laurent Soulere

Institut de Chimie et Biochimie Moléculaire et Supramoléculaire, France

Introduction
Research Keywords
bioorganic chemistry; quorum sensing modulation; FtsZ inhibitors; molecular docking; virtual screening

Prof. Dr. Anna Mitraki

Department of Materials Science and Technology, University of Crete, Greece,
Institute of Electronic Structure and Laser (I.E.S.L.), Foundation for Research and Technology - Hellas (FO.R.T.H.), Vassilika Vouton, Greece

Introduction
Research Keywords
self-assembly; viruses'adenovirus; bionanomaterials

Dr. Irina Nesmelova

University of North Carolina at Charlotte, USA

Introduction
Research Keywords
nmr; molecular interactions; protein biophysics

Registration

The registration for IECBM 2024 will be free of charge! The registration includes attendance to all conference sessions.

If you are registering several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for your understanding.

Please note that the submission and registration are two separate parts. Only scholars who registered can receive a link to access the conference live streaming. The deadline for registration is 17th April 2024.

Instructions for Authors

Procedure for Submission
IECBM 2024 will accept abstracts only. The accepted abstracts will be available online on Sciforum.net during and after the conference.
Important Deadlines
  1. Deadline for abstract submission: 23 January 2024 23 February 2024.
  2. Announcement of oral and poster abstract results: 23 February 2024 20 March 2024. You will be notified of the acceptance of an oral/poster presentation in a separate email.

Certificates of Participation are available in your logged-in area of Sciforum.net, under “My Certificates” after the conference.

Abstract Submission

Abstract submissions should be completed online by registering with www.sciforum.net and using the "Submit Abstract" function once logged into the system. No physical template is necessary.

1. The abstract structure should include the introduction, methods, results, and conclusions sections of about 200–300 words in length.
2. All accepted abstracts will be published as one dedicated volume in Proceedings (ISSN: 2504-3900) after quality check. If you wish to publish a full-length proceedings paper, please refer to the “Publication Opportunities” Section.
3. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
4. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.

Detailed Requirements:
1. The submitting author must ensure that all co-authors are aware of the contents of the abstract.
2. Please select only one presenter for each submission. If you would like to change the presenter after submission, please email us accordingly.

Note: We only accept live presentations.

Oral Presentation and Slides Submission
The slot for the oral presentation is 15 mins. We advise that your presentation lasts for a maximum of 12 mins, leaving at least 3 mins for the Q&A session.
Authors are encouraged to prepare a presentation in PowerPoint or similar software, to be displayed online along with the abstract. Slides, if available, will be displayed directly on the website using the proprietary slide viewer at Sciforum.net. Slides can be prepared in exactly the same way as for any traditional conference where research results are presented. Slides should be converted to PDF format prior to submission so that they can be converted for online display.
Poster Presentation
Poster:
  • Should include the title, authors, contact details and main research findings, as well as tables, figures and graphs where necessary.
  • File format: PDF (.pdf).
  • Size in pixel: 1080 width x 1536 height–portrait orientation.
  • Size in cm: 38,1 width x 54,2 height–portrait orientation.
  • Font size: ≥16.Examples of successful submissions can be viewed here at the following links: (1), (2), (3)
    You can use our free template to create your poster. The poster template can be downloaded HERE.
    The Poster Sessions will take place in Zoom breakout rooms. The rooms will be called after your surname. You will automatically be assigned to your breakout room, however, you will be responsible for your own room, i.e. sharing your screen by yourself, handling the comments in the chat if there are any, etc. People will then be able to visit your room and discuss your poster with you. Please make sure you have the Zoom Desktop client or mobile app, version 5.3.0 or higher.
    We will reach out to you closer to the dates of the conference with more information.
Publication Opportunities

    1. Biomolecules Journal Publication
    Participants in this conference are cordially invited to contribute a full manuscript to the conference's Special Issue, published in Biomolecules (ISSN 2218-273X, Impact Factor 5.5), with a 20% discount on the publication fee. Please note that no other discounts are applicable. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper.

    2. Proceeding Paper Publication
    You are welcome to submit a proceeding paper (4-8 pages) to MDPI Biology and Life Sciences Forum (ISSN: 2673-9976) after the conference. Publication of the proceedings will be free of charge.

    Authors are asked to disclose that it is a proceeding paper of the IECBM2024 conference paper in their cover letter. Carefully read the rules outlined in the 'Instructions for Authors' on the journal’s website and ensure that your submission adheres to these guidelines.

    Proceedings submission deadline: 10 June 2024

    Manuscripts for the proceedings issue must be formatted as follows:
    Title.
    Full author names.
    Affiliations (including full postal address) and authors' e-mail addresses.
    Abstract.
    Keywords.
    Introduction.
    Methods.
    Results and Discussion.
    Conclusions.
    Acknowledgements.
    References.

    Potential Conflicts of Interest

    It is the author's responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.

    Copyright

    MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.

    Event Awards


    To acknowledge the support of the conference's esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to announce that the conference will provide 6 awards including Best Oral Presentation Award and Best Poster Award.

    The Awards
    Best Oral Presentation Award and Best Poster Award

    Number of Awards Available: 6

    The Best Oral Presentation Award is given to the paper judged to make the most significant oral contribution to the conference.
    The Best Poster Award is given to the submission judged to make the most significant and interesting poster for the conference.

    There will be six winners selected for these awards. The winner will receive a certificate and 200 CHF each.

    Sponsors and Partners

    For information regarding sponsorship and exhibition opportunities, please click here.

    Organizers


    Media Partners

    Conference Secretariat

    Mr. Leo Zou
    Mr. Russell Wang
    Email: iecbm2024@mdpi.com

    For inquiries regarding submissions and sponsorship opportunities, please feel free to contact us.

    Top